My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Could SpaceX Overtake Nvidia As The World's B...
Intel-Backed Mobileye's Robotaxi Ambitions Ju...
CoreWeave Is 'Woefully Undervalued', Says Ana...
Netflix Flexes 'M&A Muscle' As Bidding Contes...
AI Data Center Resistance Sweeps The US As $1...
SpaceX To Buy AI Coding Startup Cursor
Moderna Strengthens Commercial Strategy As Pi...
Yum China Buys Pizza Hut Brand In China
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    BIOGEN INC (NASDAQ: BIIB)

    Overview
    current price
    $195.61
    $195.61
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    195.61
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.06 M
    1 day
    0.00 - 0.00
    52 weeks
    121.05 - 205.97
    p/e
    21.03
    beta
    0.2042
    market cap
    28.88 B
    dividend yield
    0.00%
    Industry
    -
    BIIB by TradingView
    News and Commentary
    Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
    Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards? Despite a powerful 22% surge in the S&P 500 since the April lows-driven by easing U.S.-China trade tensions and a 90-day pause on new tariffs-only half of the index's stocks have...
    Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibod... On Tuesday, the FDA approved Eli Lilly and Co's (
    Rising Stars, Falling Trends: July's Industry ETF Winners and Losers As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month.Among the largest ETFs that represent ma...
    Market Update: Dow Rallies 700 Points on Hopes Inflation is Easing Stocks staged their first rally of 2023 to close out the week higher on Friday after the December jobs report and other economic data showed signs that inflation may be cooling....
    Biogen’s Alzheimer Drug Shows Promise in Key Study For the first time, a drug has been shown to
    Market Update: Stocks Rebound from 2022 Low, Dow and S&P Snap Six-Day Losing Streak Stocks rose on Wednesday as U.S. Treasury yields retreated from multi-year highs. Benchmarks rebounded off bear market lows, with the Dow Jones Industrial Average jumping over 50...
    Medicare to Reassess Premium Hike Meant to Cover Alzheimer Drug Costs Medicare is being asked by U.S. health secretary Xavier Becerra to
    Market Update: Benchmarks Hit Record Closing Highs on Comeback Rally Wall Street benchmarks all reached record closing highs on Friday, rebounded from depressed levels in the previous session as market participants shook off concern over global ec...
    FDA Grants Approval to Biogen's Alzheimer's Treatment, Met with Controversy Biogen's (BIIB 
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?